SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Supernus Pharmaceuticals Reports No Penalties for UBS Credit Line Termination

A SEC filing says Supernus incurred no early termination penalties related to ending its UBS credit line.

SUPN

Related stories